142 related articles for article (PubMed ID: 1878537)
1. [The diagnosis of bladder carcinomas by NMR tomography: an improvement with Gd-DTPA?].
Sparenberg A; Hamm B; Hammerer P; Samberger V; Wolf KJ
Rofo; 1991 Aug; 155(2):117-22. PubMed ID: 1878537
[TBL] [Abstract][Full Text] [Related]
2. [Preoperative staging of bladder carcinomas with Gd-DTPA-supported dynamic magnetic resonance tomography. Comparison with plain and Gd-DTPA-supported spin-echo sequences].
Venz S; Hosten N; Ilg J; Mäurer J; Podrabsky P; Fedel M; Ebert T; Nagel R
Rofo; 1996 Mar; 164(3):218-25. PubMed ID: 8672777
[TBL] [Abstract][Full Text] [Related]
3. [MRT of bladder carcinoma: tumor staging and gadolinium contrast behavior].
Doringer E; Joos H; Forstner R; Schmoller H
Rofo; 1991 Apr; 154(4):357-63. PubMed ID: 1850149
[TBL] [Abstract][Full Text] [Related]
4. [Oral contrast media for magnetic resonance tomography of the abdomen. III. Initial patient research with gadolinium-DTPA].
Claussen C; Kornmesser W; Laniado M; Kaminsky S; Hamm B; Felix R
Rofo; 1988 Jun; 148(6):683-9. PubMed ID: 2837806
[TBL] [Abstract][Full Text] [Related]
5. [Gadolinium-DTPA as an oral contrast medium for magnetic resonance tomography of the pancreas].
Neumann K; Kaminsky S; Gogoll M; Clauss W; Langer M; Felix R
Rofo; 1991 Mar; 154(3):262-8. PubMed ID: 1849293
[TBL] [Abstract][Full Text] [Related]
6. Contrast-enhanced magnetic resonance imaging of the abdomen and pelvis.
Hamm B; Laniado M; Saini S
Magn Reson Q; 1990 Apr; 6(2):108-35. PubMed ID: 2202422
[TBL] [Abstract][Full Text] [Related]
7. [Determining the depth of infiltration in urinary bladder carcinoma with contrast medium enhanced dynamic magnetic resonance tomography. With reference to postoperative findings and inflammation].
Venz S; Ilg J; Ebert T; Hierholzer J; Friedrichs R; Hosten N; Felix R
Urologe A; 1996 Jul; 35(4):297-304. PubMed ID: 8928358
[TBL] [Abstract][Full Text] [Related]
8. [Role of gadolinium (Gd-DTPA) in the staging of renal carcinoma using magnetic resonance. Comparative evaluation with computerized tomography and magnetic resonance without contrast media].
De Cobelli F; Vanzulli A; Colombo E; Bonato C; Sironi S; Del Maschio A
Radiol Med; 1993 May; 85(5):562-9. PubMed ID: 8327756
[TBL] [Abstract][Full Text] [Related]
9. [Oral contrast media for the magnetic resonance tomography of the abdomen. A clinical trial of the tolerance for gadolinium-DTPA].
Kaminsky S; Laniado M; Gogoll M; Kornmesser W; Clauss W; Felix R
Rofo; 1992 Jan; 156(1):17-23. PubMed ID: 1733470
[TBL] [Abstract][Full Text] [Related]
10. [Acoustic neurinomas. Magnetic resonance tomography using the contrast medium Gd-DTPA].
Pronin IN; Kornienko VN
Zh Vopr Neirokhir Im N N Burdenko; 1995; (2):16-7. PubMed ID: 7625134
[TBL] [Abstract][Full Text] [Related]
11. [NMR tomography with gadolinium-DTPA of the trunk in pediatric oncology].
Kahn T; Fürst G; Wessalowski R; Jürgens H; Göbel U; Kemperdick HF; Mödder U
Rofo; 1989 May; 150(5):592-7. PubMed ID: 2541488
[TBL] [Abstract][Full Text] [Related]
12. [The dynamic magnetic resonance study of focal liver lesions by FLASH sequences with bolus intravenous gadolinium-DTPA].
Olivetti L; Grazioli L; Maroldi R; Matricardi L; Milanesio L
Radiol Med; 1992 Apr; 83(4):353-60. PubMed ID: 1318558
[TBL] [Abstract][Full Text] [Related]
13. [Gadolinium-DTPA as an oral contrast medium in magnetic resonance tomography].
Kaminsky S; Laniado M; Gogoll M; Kornmesser W; Clauss W; Felix R
Radiol Diagn (Berl); 1989; 30(5):541-8. PubMed ID: 2587719
[TBL] [Abstract][Full Text] [Related]
14. [The value of gadolinium-DTPA in the study of the urinary bladder].
Beyer HK; Blümm R; Hötzinger H
Rontgenpraxis; 1988 Feb; 41(2):57-64. PubMed ID: 3363435
[No Abstract] [Full Text] [Related]
15. [Magnetic resonance tomography of the oropharynx and oral cavity with Gd-DTPA. An optimized study technic and its diagnostic value].
Vogl T; Dresel S; Steger W; Grevers G; Lissner J
Rofo; 1991 Apr; 154(4):375-82. PubMed ID: 1850152
[TBL] [Abstract][Full Text] [Related]
16. [The magnetic resonance tomography of osteochondrosis dissecans of the knee joint after intravenous gadolinium-DTPA administration].
Adam G; Neuerburg J; Peiss J; Bohndorf K; Günther RW
Rofo; 1994 May; 160(5):459-64. PubMed ID: 8173056
[TBL] [Abstract][Full Text] [Related]
17. [Oral contrast medium for magnetic resonance tomography of the abdomen. II. Phase I clinical testing of gadolinium-DTPA].
Kornmesser W; Laniado M; Hamm B; Clauss W; Weinmann HJ; Schulz E; Wolf KJ; Felix R
Rofo; 1987 Nov; 147(5):550-6. PubMed ID: 2825293
[TBL] [Abstract][Full Text] [Related]
18. [Clinical application of MRI for urological malignancy. 3: A new trial of MRI for bladder cancer and prostatic cancer; surface coil and GD-DTPA].
Nishimura K; Hida S; Nishio Y; Yoshida O; Nakano Y
Hinyokika Kiyo; 1988 Dec; 34(12):2097-100. PubMed ID: 3239521
[TBL] [Abstract][Full Text] [Related]
19. [Magnetic resonance tomography of the parotid gland: plain diagnosis and Gd-DTPA].
Vogl T; Dresel S; Kang K; Grevers G; Riederer A; Späth M; Lissner J
Digitale Bilddiagn; 1989 Jun; 9(2):59-68. PubMed ID: 2546709
[TBL] [Abstract][Full Text] [Related]
20. [MRI of the nasopharynx with Gd-DTPA: its value and differential diagnostic criteria].
Vogl T; Dresel S; Schedel H; Markl A; Grevers G; Stelzer S; Lissner J
Rofo; 1989 May; 150(5):516-22. PubMed ID: 2541475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
